You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TRDA Sale Disclosure
Parmar Kush · SEC Form 4 · Filed Aug 10, 2026
Sale
Calculated transaction value
$358.37K
Parmar Kush Director
TRDA
Entrada Therapeutics
TRDA
Transaction date
Aug 7, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 3 days later
TRDA daily price context
Close on/before transaction
$6.87
Aug 7, 2026
First close after public filing
$7.04
Aug 11, 2026
30-day return after filing
+0.99%
Through Sep 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 52,317 shares @ $6.85
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001664281-26-000004
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.08M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Entrada Therapeutics, Inc. TRDA | Sale | Aug 10, 2026 | $647.11K |
| Entrada Therapeutics, Inc. TRDA Current | Sale | Aug 7, 2026 | $358.37K |
| Entrada Therapeutics, Inc. TRDA | Sale | Aug 6, 2026 | $73.46K |